HMG-CoA reductase inhibitor simvastatin suppresses Toll-like receptor 2 ligand-induced activation of nuclear factor kappa B by preventing RhoA activation in monocytes from rheumatoid arthritis patients.

Abstract:

:To investigate whether anti-inflammatory effects of HMG-CoA reductase inhibitor simvastatin (SMV) in rheumatoid arthritis (RA) is mediated by Toll-like receptor-2 (TLR-2) signal via inhibiting activation of RhoA, a small Rho GTPase that plays an important role in inflammatory responses. Peripheral blood monocytes from active RA patients were treated with Staphylococcus aureus peptidoglycan (PG), a ligand of TLR-2, in the presence or absence of SMV. RhoA activity was assessed by a pull-down assay. DNA-binding activity was measured by a sensitive multi-well colorimetric assay. Cytokine secretion was measured by ELISA. PG stimulation increased the level of active GTP-bound RhoA compared with unstimulated monocytes, and the effect of PG on RhoA activity was suppressed with anti-TLR-2 monoclonal antibody. RhoA inhibition either with a specific inhibitor or by siRNA transfection inhibited activation of NF-κB and secretion of TNFα and IL-1β in PG-induced RA monocytes. SMV mitigated PG-induced increase in RhoA activity and NF-κB activation as well as secretion of TNFα and IL-1β. The inhibitory effects of SMV were completely reversed by mevalonate and geranylgeranyl pyrophosphate. Our results indicate the modulation of RhoA on TLR-2-mediated inflammatory signaling in RA and provide a novel evidence for anti-inflammatory effects of statins through influencing TLR-2 signaling via RhoA in RA.

journal_name

Rheumatol Int

authors

Lin H,Xiao Y,Chen G,Fu D,Ye Y,Liang L,Fan J,Yang X,Sun L,Xu H

doi

10.1007/s00296-010-1510-6

subject

Has Abstract

pub_date

2011-11-01 00:00:00

pages

1451-8

issue

11

eissn

0172-8172

issn

1437-160X

journal_volume

31

pub_type

杂志文章
  • In ankylosing spondylitis serum interleukin-6 correlates with the degree of mobility restriction, but not with short-term changes in the variables for mobility.

    abstract::The aim of this study was to evaluate whether the serum concentration of interleukin-6 (IL-6) reflects disease activity in ankylosing spondylitis (AS). A group of 271 AS patients were enrolled in the study, 261 of whom completed the entire protocol (201 males, 60 females, median age of 53 years). Serum IL-6 was measur...

    journal_title:Rheumatology international

    pub_type: 临床试验,杂志文章

    doi:10.1007/s002960050066

    authors: Falkenbach A,Herold M

    更新日期:1998-01-01 00:00:00

  • Cytomegalovirus infection in systemic necrotizing vasculitis: causative agent or opportunistic infection?

    abstract::We report on a 69-year-old woman who presented with myalgia, hearing impairment, fever, night sweats, weight loss, muscular weakness, paresthesia, hypesthesia, and hypalgesia. Sural nerve biopsy showed demyelinative and axonal polyneuropathy due to necrotizing vasculitis with fibrinoid necrosis. A positive test for an...

    journal_title:Rheumatology international

    pub_type: 杂志文章

    doi:10.1007/s002960000063

    authors: Meyer MF,Hellmich B,Kotterba S,Schatz H

    更新日期:2000-12-01 00:00:00

  • Infliximab in two patients with juvenile ankylosing spondylitis.

    abstract::Infliximab, a monoclonal chimeric anti-tumor necrosis factor alpha (anti-TNF-alpha) antibody, was tried in two patients suffering from severe refractory juvenile ankylosing spondylarthritis with disease duration of more than 10 years. To assess the response, validated clinical activity parameters were monitored prospe...

    journal_title:Rheumatology international

    pub_type: 杂志文章

    doi:10.1007/s00296-003-0378-0

    authors: Schmeling H,Horneff G

    更新日期:2004-05-01 00:00:00

  • Diagnosis of Raynaud's phenomenon by 99mTc-pertechnetate hand perfusion scintigraphy: a pilot study.

    abstract::We assess the usefulness of 99mTc-pertechnetate hand perfusion scintigraphy in patients with Raynaud's phenomenon (RP). The study population consisted of 18 patients with primary RP, 25 patients with secondary RP within systemic sclerosis (SSc), and ten healthy individuals. Gamma camera dynamic first-pass study during...

    journal_title:Rheumatology international

    pub_type: 杂志文章

    doi:10.1007/s00296-016-3584-2

    authors: Pavlov-Dolijanovic S,Petrovic N,Vujasinovic Stupar N,Damjanov N,Radunovic G,Babic D,Sobic-Saranovic D,Artiko V

    更新日期:2016-12-01 00:00:00

  • A case of pure red cell aplasia and systemic lupus erythematosus caused by human parvovirus B19 infection.

    abstract::Human parvovirus B19 (B19) rarely induces pure red cell aplasia (PRCA) in healthy hosts. Meanwhile B19 infection is often clinically similar to systemic lupus erythematosus (SLE), and several cases have been reported wherein B19 actually stimulated SLE exacerbation in an immunocompetent subject. An 82-year-old healthy...

    journal_title:Rheumatology international

    pub_type: 杂志文章

    doi:10.1007/s00296-006-0227-z

    authors: Ideguchi H,Ohno S,Ishigatsubo Y

    更新日期:2007-02-01 00:00:00

  • R-h-erythropoietin counteracts the inhibition of in vitro erythropoiesis by tumour necrosis factor alpha in patients with rheumatoid arthritis.

    abstract::Anaemia of chronic disease (ACD) is a common extra-articular manifestation of rheumatoid arthritis (RA). Tumour necrosis factor alpha (TNF alpha) plays an important role in the development of ACD. The objective of the present study was to assess inhibition of in vitro colony-forming unit erythrocyte (CFUe) and blast-f...

    journal_title:Rheumatology international

    pub_type: 杂志文章

    doi:10.1007/BF00300811

    authors: Jongen-Lavrencic M,Peeters HR,Backx B,Touw IP,Vreugdenhil G,Swaak AJ

    更新日期:1994-01-01 00:00:00

  • Secondary neuropsychiatric manifestations caused by Epstein-Barr virus encephalitis in a new onset systemic lupus erythematosus patient.

    abstract::Abnormal manifestations of central nervous system in system lupus erythematosus (SLE) patients are mainly caused by primary neuropsychiatric SLE (NP-SLE). We reported a new onset SLE patient who had secondary neuropsychiatric manifestations caused by Epstein-Barr virus (EBV) encephalitis. Although EBV has an uncertain...

    journal_title:Rheumatology international

    pub_type: 杂志文章

    doi:10.1007/s00296-011-1877-z

    authors: Hongbo C,Hongzhen M,Lingzhi H,Maosheng X,Mei C

    更新日期:2012-08-01 00:00:00

  • Tocilizumab treatment in Felty's syndrome.

    abstract::Felty's syndrome (FS) is a deforming disease, characterized by the triad of rheumatoid arthritis (RA), neutropenia, and splenomegaly. Currently, FS patients are treated mainly with immunosuppressants, such as methotrexate and glucocorticoids, which however are not suitable to some patients and may cause severe side ef...

    journal_title:Rheumatology international

    pub_type: 杂志文章,评审

    doi:10.1007/s00296-020-04588-3

    authors: Li R,Wan Q,Chen P,Mao S,Wang Q,Li X,Yang Y,Dong L

    更新日期:2020-07-01 00:00:00

  • A COL2A1 gene polymorphism is related with advanced stages of osteoarthritis of the knee in Mexican Mestizo population.

    abstract::Primary osteoarthritis (OA) is a multifactorial disease with several genetics factors involved. The COL2A1 gene is of particular interest because it encodes for the most abundant protein in articular cartilage. The aim was to evaluate the association of COL2A1 gene polymorphism with OA of the knee in Mexican Mestizo p...

    journal_title:Rheumatology international

    pub_type: 杂志文章

    doi:10.1007/s00296-009-1091-4

    authors: Gálvez-Rosas A,González-Huerta C,Borgonio-Cuadra VM,Duarte-Salazár C,Lara-Alvarado L,de los Angeles Soria-Bastida M,Cortés-González S,Ramón-Gallegos E,Miranda-Duarte A

    更新日期:2010-06-01 00:00:00

  • Evidence-based, interdisciplinary guidelines for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritis.

    abstract::Uveitis in juvenile idiopathic arthritis (JIA) is frequently associated with the development of complications and visual loss. Topical corticosteroids are the first-choice therapy, and immunosuppression is commonly used. However, treatment has not been standardized. Representatives from the German Ophthalmological Soc...

    journal_title:Rheumatology international

    pub_type: 杂志文章,实务指引,评审

    doi:10.1007/s00296-011-2126-1

    authors: Heiligenhaus A,Michels H,Schumacher C,Kopp I,Neudorf U,Niehues T,Baus H,Becker M,Bertram B,Dannecker G,Deuter C,Foeldvari I,Frosch M,Ganser G,Gaubitz M,Gerdes G,Horneff G,Illhardt A,Mackensen F,Minden K,Pleyer U,

    更新日期:2012-05-01 00:00:00

  • Fibrodysplasia ossificans progressiva without characteristic skeletal anomalies.

    abstract::Fibrodysplasia ossificans progressiva (FOP) is a rare but extremely disabling genetic disease of the skeletal system. This disease is characterized by progression of heterotopic ossification within skeletal muscles, ligaments and tendons. Most patients with FOP are misdiagnosed early in life before the appearance of h...

    journal_title:Rheumatology international

    pub_type: 杂志文章

    doi:10.1007/s00296-010-1426-1

    authors: Ulusoy H

    更新日期:2012-05-01 00:00:00

  • A spontaneous intercostal artery hemorrhage in systemic lupus erythematosus.

    abstract::Systemic lupus erythematosus (SLE) is a chronic inflammatory disease that can lead to damage to several vital organs. Antiphospholipid syndrome (APS), manifesting as vascular thromboembolic events and morbidities of pregnancy in the presence of antiphospholipid antibodies (aPL), has been described in patients with SLE...

    journal_title:Rheumatology international

    pub_type: 信件

    doi:10.1007/s00296-011-1826-x

    authors: Lu CC,Chen CH,Yeh SF,Lai JH,Chang DM

    更新日期:2012-03-01 00:00:00

  • Tofacitinib for the treatment for colchicine-resistant familial Mediterranean fever: case-based review.

    abstract::Familial Mediterranean fever is characterized by self-limited attacks of serositis and arthritis. However, substantial number of patients suffer from chronic complications of this disease, primarily involving musculoskeletal system. Treatment for these complications is challenging due to limited evidence. Interleukin-...

    journal_title:Rheumatology international

    pub_type: 杂志文章,评审

    doi:10.1007/s00296-019-04490-7

    authors: Karadeniz H,Güler AA,Atas N,Satış H,Salman RB,Babaoglu H,Tufan A

    更新日期:2020-01-01 00:00:00

  • The function of myeloid dendritic cells in rheumatoid arthritis.

    abstract::Rheumatoid arthritis (RA) is a systemic autoimmune disease that causes joint pain, inflammation, and loss of function. Disease pathogenesis involves activation and proliferation of autoreactive pro-inflammatory effector T cells. While the details of RA onset and progression remain controversial, dendritic cell (DC) nu...

    journal_title:Rheumatology international

    pub_type: 杂志文章,评审

    doi:10.1007/s00296-017-3671-z

    authors: Yu MB,Langridge WHR

    更新日期:2017-07-01 00:00:00

  • Abdominal aortic aneurysm causing lumbar vertebral erosion in Behçet's disease presenting by low back pain.

    abstract::Behçet's disease (BD) is a chronic multi-system disorder commonly seen in Mediterranean, middle east and far eastern populations. In this report, we describe a case of a 55-year-old male with Behçet's disease who presented with a low back pain and sciatica. Imaging studies showed that he had a destruction of the third...

    journal_title:Rheumatology international

    pub_type: 杂志文章

    doi:10.1007/s00296-014-3077-0

    authors: Örücü M,Keleş D,Peker E,Çakıcı M,Shimbori N,Erden İ,Yazıcıoğlu L,Sonel Tur B

    更新日期:2015-02-01 00:00:00

  • Adherence to best practice consensus guidelines for familial Mediterranean fever: a modified Delphi study among paediatric rheumatologists in Turkey.

    abstract:BACKGROUND:Although not validated fully, recommendations are present for diagnosis, screening and treatment modalities of patients with familial Mediterranean fever (FMF). OBJECTIVE:To review the current practices of clinicians regarding FMF and reveal their adherence to consensus guidelines. METHODS:Fifteen key poin...

    journal_title:Rheumatology international

    pub_type: 杂志文章

    doi:10.1007/s00296-020-04776-1

    authors: Kavrul Kayaalp G,Sozeri B,Sönmez HE,Demir F,Cakan M,Oztürk K,Karadag SG,Otar Yener G,Ozdel S,Baglan E,Celikel E,Sahin N,Gezgin Yildirim D,Eker Omeroglu R,Aktay Ayaz N,PeRA-Research Group.

    更新日期:2021-01-16 00:00:00

  • Patients with the most advanced rheumatoid arthritis remain with Th1 systemic defects after TNF inhibitors treatment despite clinical improvement.

    abstract::Systemic immune defects might reflect severely dysregulated control of chronic inflammation related to disease progression. Th17/Treg cell imbalance has been demonstrated to be involved in rheumatoid arthritis (RA) pathogenesis. Despite controversial results, a growing anti-inflammatory role in this process has been r...

    journal_title:Rheumatology international

    pub_type: 杂志文章

    doi:10.1007/s00296-013-2895-9

    authors: Kosmaczewska A,Swierkot J,Ciszak L,Szteblich A,Chrobak A,Karabon L,Partyka A,Szechinski J,Wiland P,Frydecka I

    更新日期:2014-02-01 00:00:00

  • Digital ulcers as the first manifestation of carpal tunnel syndrome.

    abstract::While carpal tunnel syndrome (CTS) is the most common entrapment neuropathy presented at rheumatologic consultation, its ulcerative variant is rarely described. We report of a case of severe bilateral medial nerve palsy, presented to us for diagnosis of chronic digital ulcers which had been suspected to be rheumatolog...

    journal_title:Rheumatology international

    pub_type: 杂志文章

    doi:10.1007/s00296-009-1229-4

    authors: Perdan-Pirkmajer K,Praprotnik S,Tomšič M

    更新日期:2011-05-01 00:00:00

  • Antibodies to Sm and SS-A demonstrated by enzyme immunoassay. Correlation to clinical manifestations and disease activity in patients with systemic lupus erythematosus.

    abstract::Using commercially available antigens, enzyme-linked immunosorbent assays (ELISAs) were set up to demonstrate antibodies of IgG class against Sm and SS-A. Anti-Sm antibodies were demonstrated in 40% of patients with systemic lupus erythematosus (SLE), in 12% of patients with SJögren's syndrome, in 6% of patients with ...

    journal_title:Rheumatology international

    pub_type: 杂志文章

    doi:10.1007/BF00332564

    authors: Gripenberg M,Teppo AM,Friman C

    更新日期:1991-01-01 00:00:00

  • Association between disease activity measured by RAPID3 and health-related quality of life in patients with rheumatoid arthritis.

    abstract::Routine assessment of patient index data 3 (RAPID3) is a simple, valid and reliable tool designed to measure disease activity in patients with rheumatoid arthritis (RA). RA causes significant disability and diminishes health-related quality of life (HR-QoL). The aim of this study was to investigate how RAPID3 is relat...

    journal_title:Rheumatology international

    pub_type: 杂志文章

    doi:10.1007/s00296-019-04258-z

    authors: Qorolli M,Rexhepi B,Rexhepi S,Mustapić M,Doko I,Grazio S

    更新日期:2019-05-01 00:00:00

  • The association of anti-CCP antibodies with disease activity in rheumatoid arthritis.

    abstract::Antibodies to citrullinated proteins have been described in patients with rheumatoid arthritis (RA) and these appear to be the most specific markers of the disease. Our objective was to determine the frequency of antibodies to cyclic citrullinated peptides (CCPs) in patients with RA and the association of anti-CCP ant...

    journal_title:Rheumatology international

    pub_type: 杂志文章

    doi:10.1007/s00296-008-0570-3

    authors: Serdaroğlu M,Cakirbay H,Değer O,Cengiz S,Kul S

    更新日期:2008-08-01 00:00:00

  • Disease activity and patient-reported outcomes in patients with rheumatoid arthritis and Sjögren's syndrome enrolled in a large observational US registry.

    abstract::The objective of this study was to compare rheumatoid arthritis (RA) disease activity and patient-reported outcomes (PROs) in a national sample of patients with RA with/without Sjögren's syndrome (SS). Adults with RA from a large observational US registry (Corrona RA) with known SS status between 22 April 2010 and 31 ...

    journal_title:Rheumatology international

    pub_type: 杂志文章

    doi:10.1007/s00296-020-04602-8

    authors: Harrold LR,Shan Y,Rebello S,Kramer N,Connolly SE,Alemao E,Kelly S,Kremer JM,Rosenstein ED

    更新日期:2020-08-01 00:00:00

  • Trisomy 7 in synovial fluid cells of patients with rheumatoid arthritis.

    abstract:OBJECTIVE:Recent studies revealed trisomy 7 as a chromosomal abnormality in non-neoplastic disorders such as rheumatoid arthritis (RA). In the present study, we investigated the presence of trisomy 7 in the synovial fluid cells of patients with RA using fluorescence in situ hybridisation (FISH) analysis. METHODS:Synov...

    journal_title:Rheumatology international

    pub_type: 杂志文章

    doi:10.1007/s00296-004-0477-6

    authors: Tascioglu F,Durak B,Oner C,Artan S

    更新日期:2005-10-01 00:00:00

  • An insight into the gastrointestinal component of fibromyalgia: clinical manifestations and potential underlying mechanisms.

    abstract::Fibromyalgia syndrome is characterized by chronic generalized pain accompanied by a broad symptomatologic spectrum. Besides chronic fatigue, sleep disturbances, headaches and cognitive dysfunction that are extensively described in the literature, a considerable proportion of patients with fibromyalgia experience gastr...

    journal_title:Rheumatology international

    pub_type: 杂志文章,评审

    doi:10.1007/s00296-014-3109-9

    authors: Slim M,Calandre EP,Rico-Villademoros F

    更新日期:2015-03-01 00:00:00

  • Perforin level in CD4+ T cells from patients with systemic lupus erythematosus.

    abstract::CD4(+) T cells from patients with systemic lupus erythematosus (SLE) exhibit increased expression of various proteins contributing to defective function of CD4(+) T cells. We evaluated the transcript and protein levels of perforin (PRF1) in CD4(+) T cells from SLE patients (n = 41) and healthy individuals (n = 34). Th...

    journal_title:Rheumatology international

    pub_type: 杂志文章

    doi:10.1007/s00296-009-1329-1

    authors: Kozłowska A,Hrycaj P,Łącki JK,Jagodziński PP

    更新日期:2010-11-01 00:00:00

  • The relationship between Knee Injury and Osteoarthritis Outcome Score (KOOS) and Timed Up and Go test in patients with symptomatic knee osteoarthritis.

    abstract::Both self-reported and physical performance tests are used as outcome measures in knee osteoarthritis (OA). The aim of this study is to investigate the relationship between Knee Injury and Osteoarthritis Outcome Score (KOOS) and Timed Up and Go (TUG) test in the patients with symptomatic knee OA. Eighty-nine patients ...

    journal_title:Rheumatology international

    pub_type: 杂志文章

    doi:10.1007/s00296-012-2512-3

    authors: Sabirli F,Paker N,Bugdayci D

    更新日期:2013-10-01 00:00:00

  • Anti-Saccharomyces cerevisiae antibodies in patients with systemic lupus erythematosus.

    abstract::Anti-Saccharomyces cerevisiae antibodies (ASCA) had been known to be specific for Crohn's disease but it has been found in many other autoimmune diseases like systemic lupus erythematosus (SLE). Furthermore, cross-reactive epitopes on β2-glycoprotein I (β2GPI) and Saccharomyces cerevisiae were found in SLE patients. T...

    journal_title:Rheumatology international

    pub_type: 杂志文章

    doi:10.1007/s00296-012-2431-3

    authors: Mankaï A,Sakly W,Thabet Y,Achour A,Manoubi W,Ghedira I

    更新日期:2013-03-01 00:00:00

  • Long-term response after 6-year treatment with anakinra and onset of focal bone erosion in neonatal-onset multisystem inflammatory disease (NOMID/CINCA).

    abstract::The exact elucidation of skeletal and cartilagineous involvement in neonatal-onset multisystem inflammatory disease (NOMID) is still poorly known, and there are few data providing the long-term response to treatment with the available interleukin-1 inhibitors. We present here a 13-year-old boy with NOMID treated with ...

    journal_title:Rheumatology international

    pub_type: 杂志文章

    doi:10.1007/s00296-010-1787-5

    authors: Rigante D,Leone A,Marrocco R,Laino ME,Stabile A

    更新日期:2011-12-01 00:00:00

  • Cost-utility analysis of certolizumab pegol in combination with methotrexate in patients with moderate-to-severe active rheumatoid arthritis in Greece.

    abstract::We aimed to evaluate the cost-effectiveness of certolizumab pegol (CZP), a pegylated fc-free anti-TNF, as add-on therapy to methotrexate (MTX) versus etanercept, adalimumab, or golimumab in patients with moderate-to-severe active rheumatoid arthritis (RA) not responding to the conventional synthetic disease-modifying ...

    journal_title:Rheumatology international

    pub_type: 杂志文章

    doi:10.1007/s00296-017-3736-z

    authors: Tzanetakos C,Tzioufas A,Goules A,Kourlaba G,Theodoratou T,Christou P,Maniadakis N

    更新日期:2017-09-01 00:00:00

  • Serum deoxyribonuclease I and clinical activity in systemic lupus erythematosus.

    abstract::Serum deoxyribonuclease I (DNase I) activity in systemic lupus erythematosus (SLE) patients was shown to be lower than that of healthy laboratory personnel, rheumatoid arthritis, and scleroderma patients (P less than 0.001). The decrease in DNase I activity in SLE sera was not due to the effect of various autoantibodi...

    journal_title:Rheumatology international

    pub_type: 杂志文章

    doi:10.1007/BF00541153

    authors: Chitrabamrung S,Rubin RL,Tan EM

    更新日期:1981-01-01 00:00:00